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Introduction: The development of a pressure ulcer is an
adverse event and is often avoidable if adequate
preventive measures are applied. No large-scale data,
based on direct patient observations, are available
regarding the pressure ulcer preventive interventions
used in hospitals.
Purpose: The aim of this study was to obtain insight
into the adequacy of interventions used to prevent
pressure ulcers in Belgian hospitals.
Methods: A cross-sectional, multi-centre pressure ulcer
prevalence study was performed in Belgian hospitals.
The methodology used to measure pressure ulcer
prevalence was developed by the European Pressure
Ulcer Advisory Panel. The data collection instrument
includes five categories of data: general data, patient
data, risk assessment, skin observation and
prevention.
Results: The total sample consisted of 19 968 patients.
The overall prevalence of pressure ulcers Category
IeIV was 12.1%. Only 10.8% of the patients at risk
received fully adequate prevention in bed and while
sitting. More than 70% of the patients not at risk
received some pressure ulcer prevention while lying or
sitting.
Concusion: Generally, there is a limited use of adequate
preventive interventions for pressure ulcers in
hospitals, which reflects a rather low quality of
preventive care. The implementation of pressure ulcer
guidelines requires more attention. The pressure ulcer
prevention used in practice should be re-evaluated on
a regular basis.
INTRODUCTION
Pressure ulcers (PUs) are a serious complica-
tion of hospitalisation in terms of increased
morbidity, mortality, healthcare expenditure,
extended hospital stay and patient suffer-
ing.1e6 PU prevalence in hospitals has been
reported to range from 7% to 26%.7e13 PU
prevalence data are commonly used as an
indicator for the quality of (nursing) care.14 15
The development of a PU is an adverse
event and is (often) avoidable with adequate
prevention. Adequate PU prevention involves
assigning effective preventive measures,
consisting of a reduction of the intensity and/
or the duration of pressure and shearing
forces on the tissue, to patients at risk for PU
development.16 17
Since 2001, the Belgian evidence-based PU
prevention guideline is available and easily
accessible. So far, no large-scale data, based
on direct patient observations, are available
on PU preventive interventions carried out in
Belgian hospitals. Therefore, this study
aimed to obtain insight into the adequacy of
preventive interventions for PUs in Belgian
hospitals and evaluating PU prevalence.
METHODS
Setting and sample
This cross-sectional, multi-centre prevalence
study was carried out in Belgian hospitals. All
hospitals (n¼143), except psychiatric hospi-
tals, were invited to participate. Eighty-four
hospitals (68%) agreed to participate. All
wards were surveyed, with the exception of
day care, psychiatry, paediatric and maternity
wards. PUs are seldom observed in patients
admitted to these wards.18
Patients >18 years were included. Each
patient or relative was asked to consent to
participate in the survey. This study was
approved by the ethics review committee of
Ghent University Hospital (No
B7020072953) and of each participating
hospital.
Data collection
The methodology used to measure PU prev-
alence was developed by the European Pres-
sure Ulcer Advisory Panel (EPUAP).9 This
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methodology has been tested in different European
countries and is evaluated as sufficiently robust to
measure and compare PU prevalence and prevention in
different hospitals.9 The EPUAP method consists of
a minimum dataset and a uniform procedure.
Data collection instrument
The data collection instrument included five categories
of data: general data, patient data, risk assessment, skin
observation and prevention. General data contained
type of hospital and ward. Patient data included age,
gender and incontinence. The Braden Scale was used to
assess the PU risk of each patient. 19 This scale has been
most widely examined for its predictive validity.20 21 In
Belgium, patients with a Braden score <17 are generally
considered as being in need of preventive measures.16
Skin observation consisted of details on PUs (category
and location). PUs were categorised according to the
NPUAP-EPUAP classification system17: Category I is non-
blanchable erythema of intact skin, Category II is partial
thickness skin loss or blister, Category III is full thickness
skin loss and Category IV is full thickness tissue loss.
Finally, data on PU preventive measures included
prevention in bed and while sitting. Data on materials
used and repositioning frequency were recorded. The
use of materials was observed by the nurses. They
recorded whether the material was present in patient’s
bed or armchair and whether the patient was in bed or
in the armchair at the time of the observation. The
repositioning frequency was based on the reported
frequency in the patient chart. Both evidence-based
effective and non-effective measures were registered.
The data collection instrument was developed using the
software package SNAP Surveys V.SNAP 9 Professional
(Snap Surveys, Inc).
Procedure
In each participating hospital a supervisor was appointed
who was responsible for the local organisation of the
study. Prior to the study, all supervisors attended
a training session. This consisted of: (1) a theoretical
training (pathophysiology, classification, risk assessment
using the Braden Scale and prevention); (2) an intro-
duction to the study aims and protocol and (3) the use
of the data collection instrument. The purpose of this
training was to ensure the correctness and uniformity of
completing the data collection instrument.
The supervisor composed teams of nurses who
collected the data on the wards. Each team consisted of
two nurses: a nurse from the staff of the ward being
surveyed and a nurse working in another ward. The first
nurse could provide relevant background information
about individual patients. Accordingly, all patients were
observed by two nurses. Both nurses had to agree about
the PU classification. If they disagreed, the opinion of
the non-ward nurse was decisive.
The supervisors instructed the teams about the study
procedure. Therefore, supervisors received a PowerPoint
presentation and an information guide on the study
procedure to increase the reliability of the data collec-
tion.22 23
For practical reasons, participating wards were allowed
to choose one day between 15 and 25 April 2008 to
perform the study.
Data analysis
The adequacy of PU preventive interventions was
assessed for patients at risk (Braden score <17 or having
a PU) according to a predefined algorithm (figure 1).
This algorithm was constructed based on the Belgian
evidence-based PU prevention guideline.16 The algo-
rithm took into account the prevention while lying in
bed, including type of mattress, repositioning scheme
and offloading the heels from the mattress, and while
sitting in an armchair, including type of cushion and
repositioning scheme.16 An assessment of whether
patients not at risk for PU development received no PU
prevention was also carried out.
All statistical analyses were performed with the soft-
ware package SPSS V.15.0 (SPSS, Inc). Descriptive data
are presented in frequencies and percentages. The
overall prevalence of PUs was based on the number of
patients with a PU. If a patient had different PUs, the PU
with the severest category was taken into account.
Figure 1 Algorithm of adequate
preventive measures for patients
at risk.
Standard cushion or 
In an (arm)chair
Pressure-
In bed
Non-pressure Dynamic mattressPressure-
no cushion redistributing
cushion
Repositioning Repositioning
redistributing
mattress
redistributing
mattress
RepositioningRepositioningRepositioning
1 hourly 2-3 hourly
Heels elevated from the mattress
not needed2-4 hourly2 hourly
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RESULTS
In total, 1005 out of 2043 potential hospital wards
participated. The total sample consisted of 19 968
patients. The majority of the patients (62.4%) were
admitted to surgical and medical wards (table 1). Almost
60% of the patients were aged $70 years and about 25%
were at risk for PUs according to the Braden Scale.
The overall prevalence of PUs Category IeIV was
12.1% and Category IIeIV was 7%. Intensive care units
and geriatric wards had the highest prevalence figures
(table 2). Table 3 provides details on the location and
categories of PUs. Sacrum and heels were most
frequently affected locations. This analysis was based on
the total number of PUs observed.
Findings on the adequacy of the applied prevention by
ward type are provided in table 4. In intensive care units,
the highest percentage of patients at risk (30.4%)
received adequate preventive measures in bed and while
sitting in an armchair, whereas on wards with surgical
patients the lowest figures (6.2%, 6.6%) were reported.
Overall, only 10.8% of the patients at risk received fully
adequate prevention. The majority of patients at risk
(73.5%) received partly adequate prevention, which was
defined as not all required preventive measures were
applied in bed and/or armchair. Generally, a higher
percentage of patients at risk received adequate
prevention in an armchair (34%) than in bed (25.5%).
More than 70% of the patients not at risk received
(some) prevention while lying or sitting (table 4).
Details on inadequate preventive measures in at risk
patients are presented in table 5. Heels were not
offloaded in 60.8% of the patients at risk. While sitting,
the most occurring failure was patients having a standard
Table 2 Prevalence of pressure ulcers Category IeIV and Category IIeIV by ward type (N¼19968)
Pressure ulcers Category IeIV Pressure ulcers Category IIeIV
n (%) n (%)
Surgical wards 426 (8.1) 226 (4.3)
Medical wards 648 (11.1) 361 (6.2)
Surgicalemedical wards 85 (6.4) 42 (3.2)
Geriatric wards 609 (18.9) 395 (12.3)
Intensive care units 164 (19.9) 107 (13.0)
Other wards 487 (14.1) 265 (7.8)
Total 2419 (12.1) 1396 (7.0)
Table 3 Location and categories of the pressure ulcers* by ward type (N¼19968)
Surgical
wards
Medical
wards
Surgicalemedical
wards
Geriatric
wards
Intensive
care units
Other
wards Total
Location n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Sacrum 285 (52.2) 435 (51.6) 61 (55.5) 359 (45.4) 93 (40.2) 256 (44.5) 1489 (48.1)
Category I 149 (27.3) 227 (27.1) 31 (28.2) 144 (18.2) 37 (16.0) 147 (25.5) 735 (23.8)
Category II 66 (12.1) 115 (13.7) 16 (14.5) 91 (11.5) 36 (15.6) 66 (11.5) 390 (12.6)
Category III 41 (7.5) 63 (7.5) 7 (6.4) 76 (9.6) 16 (6.9) 39 (6.8) 242 (7.8)
Category IV 29 (5.3) 30 (3.6) 7 (6.4) 48 (6.1) 4 (1.7) 4 (0.7) 122 (3.9)
Heels 199 (36.5) 277 (33.1) 38 (34.6) 341 (43.2) 80 (34.7) 249 (43.2) 1184 (38.4)
Category I 96 (17.6) 114 (13.6) 23 (20.9) 125 (15.8) 31 (13.4) 113 (19.6) 502 (16.2)
Category II 33 (6.1) 61 (7.3) 8 (7.3) 70 (8.9) 22 (9.6) 40 (6.9) 234 (7.6)
Category III 35 (6.4) 47 (5.6) 6 (5.5) 73 (9.2) 16 (6.9) 47 (8.2) 224 (7.3)
Category IV 35 (6.4) 55 (6.6) 1 (0.9) 73 (9.3) 11 (4.8) 49 (8.5) 224 (7.3)
Hips 8 (1.6) 23 (2.8) 3 (2.7) 25 (3.2) 10 (4.3) 13 (2.2) 82 (2.6)
Category I 1 (0.2) 14 (1.7) 2 (1.8) 10 (1.3) 4 (1.7) 7 (1.2) 38 (1.2)
Category II 1 (0.2) 2 (0.3) 0 (0.0) 6 (0.8) 3 (1.3) 3 (0.5) 15 (0.5)
Category III 3 (0.6) 6 (0.7) 1 (0.9) 4 (0.5) 1 (0.4) 0 (0.0) 15 (0.5)
Category IV 3 (0.6) 1 (0.1) 0 (0.0) 5 (0.6) 2 (0.9) 3 (0.5) 14 (0.4)
Other 53 (9.7) 103 (12.2) 8 (7.2) 66 (8.2) 48 (20.8) 58 (10.1) 336 (10.9)
Category I 27 (4.9) 47 (5.6) 5 (4.5) 27 (3.4) 14 (6.1) 20 (3.5) 140 (4.5)
Category II 10 (1.8) 27 (3.2) 1 (0.9) 17 (2.1) 19 (8.2) 16 (2.8) 90 (2.9)
Category III 13 (2.4) 17 (2.0) 2 (1.8) 13 (1.6) 7 (3.0) 15 (2.6) 67 (2.2)
Category IV 3 (0.6) 12 (1.4) 0 (0.0) 9 (1.1) 8 (3.5) 7 (1.2) 39 (1.3)
Total 545 383 110 791 231 576 3091
*Based on the total number of pressure ulcers observed.
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cushion or no cushion in combination with an inade-
quate repositioning frequency (72.3%).
DISCUSSION
This study revealed a PU prevalence of 12.1% in Belgian
hospitals, which is in line with other international stud-
ies.7e13 The PU prevalence was the highest on geriatric
and intensive care wards and the heels and sacrum were
the most affected sites. Both these findings are also
consistent with other international studies.7e13 Geriatric
and intensive care patients are high risk patients to
develop PUs. They have multiple risk factors, such as
limited mobility and activity, higher age, perfusion and
oxygenation problems, and a reduced general health
status, which explains their high level of risk.24e30 The
proportion of sacral and heel PUs was rather high.
Specifically, heel PUs are often viewed as a (outcome)
quality indicator, as most heel ulcers can easily be
prevented.16
The main purpose of this study was to gain insight into
the adequacy of preventive interventions for PUs in
Belgian hospitals. This gives us more information about
the process of nursing care and can be used as a quality
indicator. The results of this study indicate that the
adequacy of PU prevention in Belgian hospitals was
suboptimal. Only 1 out of 10 patients at risk for PUs
received fully adequate prevention. A significant number
of patients not at risk received some kind of preventive
measure which is, in fact, unnecessary and inefficient.2 31
Prevention while sitting and heel prevention can be
described as problematic. Prevention while sitting is of
utmost importance as the pressure on the sacrum is
higher in the sitting position compared to the lying
Table 4 Adequate pressure ulcer (PU) prevention in patients at risk (Braden score <17 or PU) and not at risk by ward type
Surgical
wards
Medical
wards
Surgicale
medical
wards
Geriatric
wards
Intensive
care units
Other
wards Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Patients at risk 1123 1429 241 1372 543 1205 5913
In bed and armchair
Fully adequate
prevention*
74 (6.6) 121 (8.5) 15 (6.2) 165 (12.0) 165 (30.4) 96 (8.0) 636 (10.8)
Partly adequate
preventiony
852 (75.9) 1034 (75.9) 178 (73.9) 1001 (73.0) 323 (59.5) 960 (79.7) 4348 (73.5)
No adequate
preventionz
197 (17.5) 274 (19.2) 48 (19.9) 206 (15.0) 55 (10.1) 149 (12.4) 929 (15.7)
In bed
Fully adequate
prevention
196 (17.5) 298 (20.9) 33 (13.7) 501 (36.5) 196 (36.1) 283 (23.5) 1507 (25.5)
Partly adequate
prevention
789 (70.3) 974 (68.2) 169 (70.1) 811 (59.1) 312 (57.5) 832 (69.0) 3887 (65.7)
No adequate
prevention
138 (12.3) 157 (11.0) 39 (16.2) 60 (4.4) 35 (6.4) 90 (7.5) 519 (8.8)
In armchair
Fully adequate
prevention
426 (37.9) 442 (30.9) 86 (35.7) 327 (28.3) 440 (81.0) 290 (24.1) 2011 (34.0)
Partly adequate
prevention
171 (15.2) 214 (15.0) 27 (11.2) 430 (31.3) 23 (4.2) 385 (32.0) 1250 (21.1)
No adequate
prevention
526 (46.8) 773 (54.1) 128 (53.1) 615 (44.8) 80 (14.7) 530 (44.0) 2652 (44.9)
Patients not at risk 4153 4419 1091 1850 281 2261 14055
In bed and armchair
Correct: no prevention 1269 (30.6) 1391 (31.5) 370 (33.9) 427 (23.1) 47 (16.7) 580 (25.7) 4084 (29.1)
Incorrect: prevention 2884 (69.4) 3028 (68.5) 721 (66.1) 1423 (76.9) 234 (83.3) 1681 (74.3) 9971 (70.9)
In bed
Correct: no prevention 1333 (32.1) 1441 (32.6) 377 (34.6) 501 (27.1) 56 (19.9) 641 (28.4) 4349 (30.9)
Incorrect: prevention 2820 (67.9) 2978 (67.4) 714 (65.4) 1349 (72.9) 225 (80.1) 1620 (71.6) 9709 (69.1)
In armchair
Correct: no prevention 3908 (94.1) 4221 (95.5) 1072 (98.3) 1461 (79.0) 238 (84.7) 1913 (84.6) 12813 (91.2)
Incorrect: prevention 245 (5.9) 198 (4.5) 19 (1.7) 389 (21.0) 43 (15.3) 348 (15.4) 1242 (8.8)
*Effective preventive measures.
ysome preventive measures.
zno preventive measures.
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position. Adequate prevention of heel PUs requires
a complete relief of pressure/shear at the heel zone.
This is necessary because of the combination of
a microcirculatory system, which is very susceptible to
pressure and shearing alterations, and the normal
physiological changes of the skin in aged patients.
Moreover, the heel surface is too small to spread pres-
sure through devices.32 In fact, the principle of elevating
the heels from the mattress by a device such as a (wedge-
shaped) cushion, a heel pad or a heel boot is recom-
mended and should be easily attainable.17
Other international studies reported similar worri-
some findings concerning the use of adequate PU
prevention in hospitals. In a Swedish study, the majority
of patients at risk for or with PUs did not get appropriate
prevention while in bed or sitting in a chair.33 Bours et al
found that only half of the patients who needed a pres-
sure-redistributing mattress were positioned on such
a support surface and that less than 33% of the patients
needing to be repositioned were actually being turned.18
Lyder et al evaluated national estimates of compliance
with the process of care for patients at risk for PU. They
found that a pressure-reducing device was used for only
7.5% of those patients and that 66.2% were reposi-
tioned.34 Baumgarten et al (2010) studied the use of
pressure-redistributing support surfaces among elderly
hip fracture patients.35 They found that this surface was
present in only 36.4% of their observations. A European
pilot survey revealed that only 9.7% of the patients in
need of prevention received adequate preventive care.9
A Belgian study, investigating the use of hospital
administrative data to evaluate the knowledge-to-action
gap in PU preventive care, found that Belgian hospitals
frequently failed to provide appropriate prevention.36 In
that study, 17.5% of the patients who should have been
placed on a dynamic mattress were not. However, in that
study no detailed information is given on the preventive
strategies as a rather rough algorithm was constructed to
evaluate PU prevention.36
Generally, there is a limited use of effective preventive
interventions for PUs in hospitals, which reflects a rather
low quality of PU preventive care resulting in adverse
outcomes for patients. This finding is striking because
several initiatives have been taken to address the gap
between research evidence and clinical practice, which is
one of the most persistent problems in the provision of
quality healthcare.37 Evidence-based guidelines16 and
e-learning packages on PU classification and prevention
Table 5 Inadequate pressure ulcer (PU) preventive measures in at risk patients (Braden score <17 or PU) by ward type
(N¼5913)
Surgical
wards
Medical
wards
Surgicale
medical
wards
Geriatric
wards
Intensive
care units
Other
wards Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Patients at risk 1123 1429 241 1372 543 1205 5913
In bed
Mattress
Standard mattress with no
adequate repositioning frequency
202 (18.0) 237 (16.6) 58 (24.1) 131 (9.5) 16 (0.3) 136 (11.3) 780 (13.2)
Pressure-redistributing mattress
with no adequate repositioning
frequency
533 (47.5) 497 (34.8) 91 (37.7) 310 (22.6) 77 (1.4) 389 (32.3) 1897 (32.1)
Total 735 (65.5) 734 (27.5) 149 (61.8) 441 (32.1) 93 (1.7) 525 (43.6) 2677 (45.3)
Heel prevention
Heels not elevated from the
mattress
674 (18.7) 967 (26.9) 168 (4.7) 716 (19.9) 323 (9.0) 748 (20.8) 3596 (60.7)
Mattress(1) + heel prevention
Inadequate prevention on
mattress and heels not elevated
from mattress
927 (21.0) 1131 (25.7) 208 (4.7) 871 (19.8) 347 (7.9) 922 (20.9) 4406 (74.5)
In armchair
Cushion
Standard cushion or no cushion
with no adequate repositioning
frequency
532 (47.4) 800 (56.0) 131 (5.4) 700 (51.0) 81 (1.5) 577 (47.9) 2821 (47.7)
Pressure-redistributing cushion
with no correct repositioning
frequency
165 (14.7) 187 (13.1) 24 (0.6) 345 (25.1) 22 (0.4) 338 (28.0) 1081 (18.3)
Total 697 (62.1) 987 (69.1) 155 (4.0) 1045 (76.1) 103 (1.9) 915 (75.0) 3901 (66.0)
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are freely and easily accessible, and educational meetings
have also been organised. These strategies have not had
the expected outcome. Other strategies such as the use
of reminders and feedback or a combination of different
strategies may be more effective.38 First, it is important to
identify barriers for adequate prevention, such as
knowledge, attitude or clearly defined responsibilities,
priority, availability of equipment, costs.37e39 To increase
their effectiveness, implementation strategies should
address these barriers.40 The use of tailored multifaceted
implementation strategies is another possible option.
These strategies may probably improve PU care and
patient outcomes since they have been shown to have
potential.41 42
Limitations
The present study was the largest study inventorying the
PU prevalence and preventive interventions in Belgian
hospitals based on direct patient observations. Almost
70% of all Belgian hospitals participated and approxi-
mately half of the eligible wards participated including
almost 20 000 patients. This may possibly have an influ-
ence on the representativeness of the sample.
The data on the use of PU prevention materials were
based on the observations and reports of the nurses. The
repositioning frequency was based on the report in the
patient chart and provides only an impression on its
reporting. It is possible that these data are over-
estimations of the actually executed prevention and that
the real figures are somewhat lower.
The algorithm to define adequate preventive measures
was based on the Belgian evidence-based PU prevention
guideline. However, we need to take into account that
there is still a lack of evidence about the effectiveness of
PU preventive measures.43
CONCLUSION
The overall prevalence of PUs Category IeIV was 12.1%
in Belgian hospitals. Only 10% of the patients received
adequate PU prevention. This study indicates that it is
possible to improve the quality of preventive care.
Consequently, the incidence of PUs might decrease. The
biggest improvement can be gained in the prevention
while sitting and the prevention specific for heels. An
interesting challenge for the hospitals is to effectively
disseminate and implement PU prevention guidelines to
individual wards and to address barriers. This may
probably improve the quality of PU care and patient
outcomes.
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